Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

An audit strategy for progression-free survival.

Dodd LE, Korn EL, Freidlin B, Gray R, Bhattacharya S.

Biometrics. 2011 Sep;67(3):1092-9. doi: 10.1111/j.1541-0420.2010.01539.x. Epub 2011 Jan 6.

PMID:
21210772
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Blinded independent central review of progression-free survival in phase III clinical trials: important design element or unnecessary expense?

Dodd LE, Korn EL, Freidlin B, Jaffe CC, Rubinstein LV, Dancey J, Mooney MM.

J Clin Oncol. 2008 Aug 1;26(22):3791-6. doi: 10.1200/JCO.2008.16.1711. Review. Erratum in: J Clin Oncol. 2009 Apr 20;27(12):2109-10.

PMID:
18669467
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

[Health related quality of life and endpoints in oncology].

Bonnetain F.

Cancer Radiother. 2010 Oct;14(6-7):515-8. doi: 10.1016/j.canrad.2010.06.001. Epub 2010 Jul 31. Review. French.

PMID:
20674446
[PubMed - indexed for MEDLINE]
4.

US FDA draft Guidance Standard for Clinical Trial Imaging Endpoints: more than just imaging?

Walovitch RC, Chokron P, Agarwal S.

Biomark Med. 2012 Dec;6(6):839-47. doi: 10.2217/bmm.12.74. Review.

PMID:
23227850
[PubMed - indexed for MEDLINE]
5.

Bisphosphonates for breast cancer.

Pavlakis N, Schmidt R, Stockler M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003474. Review. Update in: Cochrane Database Syst Rev. 2012;2:CD003474.

PMID:
16034900
[PubMed - indexed for MEDLINE]
6.

Analysis of progression-free survival in oncology trials: some common statistical issues.

Carroll KJ.

Pharm Stat. 2007 Apr-Jun;6(2):99-113. Review.

PMID:
17243095
[PubMed - indexed for MEDLINE]
7.

Progression-free survival is simply a measure of a drug's effect while administered and is not a surrogate for overall survival.

Wilkerson J, Fojo T.

Cancer J. 2009 Sep-Oct;15(5):379-85. doi: 10.1097/PPO.0b013e3181bef8cd. Review.

PMID:
19826357
[PubMed - indexed for MEDLINE]
8.

Optimal primary surgical treatment for advanced epithelial ovarian cancer.

Elattar A, Bryant A, Winter-Roach BA, Hatem M, Naik R.

Cochrane Database Syst Rev. 2011 Aug 10;(8):CD007565. doi: 10.1002/14651858.CD007565.pub2. Review.

PMID:
21833960
[PubMed - indexed for MEDLINE]
9.

High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults.

Schaaf M, Reiser M, Borchmann P, Engert A, Skoetz N.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD007678. doi: 10.1002/14651858.CD007678.pub2. Review.

PMID:
22258971
[PubMed - indexed for MEDLINE]
10.

A systematic review evaluating the relationship between progression free survival and post progression survival in advanced ovarian cancer.

Sundar S, Wu J, Hillaby K, Yap J, Lilford R.

Gynecol Oncol. 2012 May;125(2):493-9. doi: 10.1016/j.ygyno.2011.12.420. Epub 2011 Dec 8. Review.

PMID:
22155676
[PubMed - indexed for MEDLINE]
11.

Surrogate end points for median overall survival in metastatic colorectal cancer: literature-based analysis from 39 randomized controlled trials of first-line chemotherapy.

Tang PA, Bentzen SM, Chen EX, Siu LL.

J Clin Oncol. 2007 Oct 10;25(29):4562-8. Epub 2007 Sep 17. Review.

PMID:
17876010
[PubMed - indexed for MEDLINE]
Free Article
12.

Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.

Nair B, Wilt T, MacDonald R, Rutks I.

Cochrane Database Syst Rev. 2002;(1):CD003506. Review.

PMID:
11869665
[PubMed - indexed for MEDLINE]
13.

Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.

Winter-Roach BA, Kitchener HC, Dickinson HO.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD004706. doi: 10.1002/14651858.CD004706.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;3:CD004706.

PMID:
19588360
[PubMed - indexed for MEDLINE]
14.

Design and endpoints of clinical trials in hepatocellular carcinoma.

Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M, Talwalkar J, Gores GJ; Panel of Experts in HCC-Design Clinical Trials.

J Natl Cancer Inst. 2008 May 21;100(10):698-711. doi: 10.1093/jnci/djn134. Epub 2008 May 13. Review.

PMID:
18477802
[PubMed - indexed for MEDLINE]
Free Article
15.

Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer.

Wagner AD, Thomssen C, Haerting J, Unverzagt S.

Cochrane Database Syst Rev. 2012 Jul 11;7:CD008941. doi: 10.1002/14651858.CD008941.pub2. Review.

PMID:
22786517
[PubMed - indexed for MEDLINE]
16.

Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.

Gibson LJ, Dawson C, Lawrence DH, Bliss JM.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003370. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD003370.

PMID:
17253488
[PubMed - indexed for MEDLINE]
17.

Survival end point reporting in randomized cancer clinical trials: a review of major journals.

Mathoulin-Pelissier S, Gourgou-Bourgade S, Bonnetain F, Kramar A.

J Clin Oncol. 2008 Aug 1;26(22):3721-6. doi: 10.1200/JCO.2007.14.1192. Review.

PMID:
18669458
[PubMed - indexed for MEDLINE]
Free Article
18.

Bisphosphonates for breast cancer.

Pavlakis N, Stockler M.

Cochrane Database Syst Rev. 2002;(1):CD003474. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD003474.

PMID:
11869664
[PubMed - indexed for MEDLINE]
19.

The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias.

Tharmanathan P, Calvert M, Hampton J, Freemantle N.

BMC Med Res Methodol. 2008 Mar 20;8:12. doi: 10.1186/1471-2288-8-12. Review.

PMID:
18366697
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.

Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.

Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.

PMID:
16545208
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk